Targeting breast cancer metastasis with ID1
Ended Project Grant Awarded Last action
- Award ID
- R44CA206723
- Recipient
-
Organix Chemistry Solutions LLC UEI HEGURQ5WJRQ9
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,724,385
Award facts
- Assistance listing
- 93.395 Cancer Treatment Research
- Completion date
- Originally
- Funding
-
- $1,726,748.40 Federal
- -$2,363.30 Non-federal
- Place of performance
- Woburn, MA 01801, USA
Award details come from USAspending.gov.
Transactions
| Action | Federal | Non-federal | Date |
|---|---|---|---|
| Amendment | -$2,363 | $0 | |
| Amendment | -$2,363 | -$2,363 | |
| Amendment | $2,000 | $0 | |
| Amendment | $741,502 | $0 | |
| Amendment | $809,827 | $0 | |
| Amendment | $0 | $0 | |
| Original award | $178,146 | $0 |
Quick answers
Who received award R44CA206723?
R44CA206723 was awarded to Organix Chemistry Solutions LLC by National Cancer Institute (National Institutes of Health) on September 1, 2016.
How much is award R44CA206723 worth?
$1,724,385 has been obligated on R44CA206723: $1,726,748 in federal funding and -$2,363 in non-federal funding.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award